1. Home
  2. KAI vs DYN Comparison

KAI vs DYN Comparison

Compare KAI & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kadant Inc

KAI

Kadant Inc

HOLD

Current Price

$321.12

Market Cap

3.4B

Sector

Industrials

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$17.96

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KAI
DYN
Founded
1991
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.4B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
KAI
DYN
Price
$321.12
$17.96
Analyst Decision
Buy
Strong Buy
Analyst Count
2
17
Target Price
$340.00
$39.94
AVG Volume (30 Days)
126.2K
2.0M
Earning Date
02-11-2026
02-26-2026
Dividend Yield
0.41%
N/A
EPS Growth
N/A
N/A
EPS
8.65
N/A
Revenue
$1,024,074,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$10.56
N/A
P/E Ratio
$37.99
N/A
Revenue Growth
N/A
N/A
52 Week Low
$244.87
$6.36
52 Week High
$409.73
$25.00

Technical Indicators

Market Signals
Indicator
KAI
DYN
Relative Strength Index (RSI) 60.99 48.05
Support Level $310.20 $16.00
Resistance Level $334.50 $17.50
Average True Range (ATR) 11.40 0.95
MACD 1.30 0.03
Stochastic Oscillator 76.70 51.92

Price Performance

Historical Comparison
KAI
DYN

About KAI Kadant Inc

Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, & filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence in the U.S., China, Asia, Germany, Canada, and Others.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: